Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
123 results
  1. Results - Evidence for the Reaffirmation of the U.S. Preventive Services Task Force Recommendation on Screening for ... 
    https://www.ncbi.nlm.nih.gov/books/NBK33943
    ... blocker (carvedilol) for 16 weeks, and, after a placebo washout period, were crossed over to the alternative regimen for another 16 weeks; 40 men were randomly assigned to receive placebo. Results indicated that carvedilol caused a decline in ...
  2. List of Excluded and Background Studies - ADHD Diagnosis and Treatment in Children and Adolescents - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK603009
    ... caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes’ analysis. Arch Gen Psychiatry. 1978 Apr;35(4):463–73. doi: 10.1001/archpsyc.1978.01770280073008. PMID: 365123. Population ... disorder: placebo-controlled double-blind pilot trial alone and combined ...
  3. Excluded Studies - Treatment of Depression in Children and Adolescents: A Systematic Review - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK555854
    ... 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- ...
  4. Evidence Table - Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK61787
    ... adequate?: NR Baseline/run-in period: 4 weeks placebo run-in Washout period(s): 2 weeks Duration of treatment: 26 ... 140-179 mm Hg after 2 weeks of washout with placebo Exclusion criteria: NR 1) Blood pressure: Change in ...
  5. NLM Digital Collections - Modulator treatments for cystic fibrosis : effectiveness and value 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 27, 2020
    resource.nlm.nih.gov/101769589
    ... 4.4 (0 to without appropriate 18.3) washout Placebo: 7.3 (5.2 to 8.2) Difference ... between) 98.5 (6.4) difference (p-value) washout for 4 −2.22 (p=0.0097) weeks, and 150mg placebo every 12 hours for 4 weeks OR (2) ...
  6. Non-pharmacological management of motor and non-motor symptoms - Parkinson’s disease in adults: diagnosis and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK535845
    ... trials have been of parallel group design and placebo controlled. A washout period at the end of the study was often included to remove the symptomatic effects of the active agent. In general, ... given placebo. 99 With this technique one group is randomised ...
  7. NLM Digital Collections - Single-Drug Therapy for Hypertension in Men: A Comparison of Six Antihypertensive Agents with ... 
    Publication: Massachusetts Medical Society, 1 April 1993
    resource.nlm.nih.gov/101584929X130
    ... of 95 to 109 mm Hg, after a placebo washout period, to receive placebo or one of six ... maintenance phase, each patient entered a four-week placebo washout phase. Patients who had been randomly assigned to ...
  8. NLM Digital Collections - Modulator treatments for cystic fibrosis : effectiveness and value : final evidence report ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018
    resource.nlm.nih.gov/101744956
    ... four- weeks, and 150mg Mean, percentage value) week washout placebo every 12 hours points (SD) −2.22 (p= ... 4) for 4 weeks OR (2) 150mg of placebo every 12 hours for 4 weeks, washout for 4 weeks, and 150mg ivacaftor every 12 ...
  9. Results - Medical Therapies for Children With Autism Spectrum Disorder—An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK448267
    ... with moderate risk of bias compared melatonin or placebo for 3 months followed by a 1-month washout and 3 months of either melatonin or placebo. 68 Sleep latency and total sleep were significantly ...
  10. NLM Digital Collections - Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension after ... 
    Publication: The American Medical Association, 11 September 1995
    resource.nlm.nih.gov/101584929X123
    ... failed an active treatment and withdrew during the placebo washout phase, the com- bined response rate was 76. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last